MADISON, Wis. and ROME, Dec. 1, 2016 /PRNewswire/ -- Propeller Health, the leading digital solution for respiratory medicine and Medical International Research (MIR), a global leader in spirometry, oximetry and telemedicine, today announced a collaboration to integrate several of MIR's mobile and clinical spirometers into the Propeller system.
Lung function measurements provide a physiological perspective on diseases such as asthma and chronic obstructive pulmonary disease (COPD). With regular assessment, spirometry can help patients and physicians determine whether the disease is progressing, and how patients are responding to treatment. With the addition of MIR spirometers to its platform, Propeller is the only commercially marketed respiratory digital health solution to include FDA cleared inhaler sensors, digital interfaces and truly mobile spirometers.
Healthcare organizations and pharmaceutical partners using Propeller can incorporate MIR's spirometers into their clinical and commercial programs, thereby adding another important signal in the digital management of patients with asthma and COPD. Data from these devices will be automatically routed to the Propeller platform where patients and physicians can evaluate their status.
"We're excited to partner with MIR to introduce their connected spirometers to participants in Propeller," said David Van Sickle, CEO. "Periodic assessment can be helpful in monitoring whether treatment is truly controlling symptoms and improving quality of life. These next-generation, mobile spirometers make it possible for patients to better understand their lung function at home and in the community."
"I am excited about this partnership with Propeller as it offers our customers a new option in the digital management of respiratory diseases making available a comprehensive range of sensors. It happens at the right time now that MIR has launched a new generation of truly "Smart" spirometers, which provide the same accuracy of a clinical setting and connect wirelessly to the Propeller System," commented John Cello, National Sales and Business Development Manager– MIR USA Inc.
Propeller empowers people with asthma and COPD to live measurably better lives. In 2010, Propeller set out to modernize respiratory medicine, help people minimize the impact of asthma and COPD on their daily lives, and connect them to their physicians, environment and community. Propeller's information-powered approach to respiratory management guides physicians and patients to the optimal path of therapy for each individual. With connected inhalers, digital interfaces, mobile spirometers and real-time personalized insights, participants receive personal guidance and expert direction anytime. Backed by 3M Ventures (NYSE: MMM), SR One (venture capital arm of GSK), Hikma Ventures (LON: HIK), Safeguard Scientifics (NYSE: SFE), Social Capital and other investors, Propeller has been used by patients with asthma or COPD in over 45 commercial programs across the US at major healthcare systems, payers, employers and other commercial partners. The company has been recognized as the recipient of the American Telemedicine Association's 2016 President's Award for Innovation in Remote Healthcare and as one of the top "Fierce 15" medical device companies in 2015 by FierceMedicalDevices. For more information visit: www.propellerhealth.com
Since 1993, MIR Italy designs, develops, manufactures and distributes a highly technological, innovative and comprehensive range of portable spirometers, oximeters and solutions for telemedicine, clinical trials and patient self-monitoring. The cornerstone of MIR spirometry technology is the FlowMIR disposable turbine. User-friendliness makes all our devices ideal for both specialists and family doctors. MIR is one of the most active companies in the world for emerging trends like wireless real-time health monitoring and truly mobile instruments for personal care providing fast and intuitive solutions for modern professionals. MIR continues to strive for advancement of spirometry technology with many new products on the horizon reflecting the evolving needs of modern healthcare. Today MIR, Medical International Research, is present in more than 93 countries worldwide.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/propeller-and-mir-announce-license-agreement-and-collaboration-to-integrate-mobile-and-clinic-based-spirometers-into-the-propeller-platform-300371170.html
SOURCE Propeller Health